Clinical toxicity of cytokines used as haemopoietic growth factors.
about
Post orgasmic illness syndrome (POIS)Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Acute neurologic complications in children with systemic cancer.Management of thrombocytopenia due to liver cirrhosis: a reviewComplex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein.Development of a recombinant growth factor and fusion protein: lessons from GM-CSF.Postorgasmic illness syndrome: two cases.The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammationSelective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization.Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disorders.In-vitro Behavior of Human Umbilical Cord Blood Stem Cells Towards Serum Based Minimal Cytokine Growth ConditionsIL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells.GM-CSF as successful salvage therapy of metamizole (dipyrone)-induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent.Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes.The effect of acupuncture on proinflammatory cytokine production in patients with chronic headache: a preliminary report.A study of the effect of sequential injection of 5-androstenediol on irradiation-induced myelosuppression in mice.Monoaminergic regulation of hemopoiesis under extreme conditions.
P2860
Q28066724-2B2B9E71-0BBE-49CB-A28D-99D4F74F9690Q31109638-EADAC8A7-10E2-4514-880B-B700FB72F918Q33145961-1F3A69C1-D91C-4EC3-BABE-6093D8FC32D0Q33413924-41DF494D-C35F-40B1-8D0D-1AF4D33DC7D8Q33417707-CEB1E180-7978-4F8B-9606-2C511B1A865FQ33657656-0570C0BA-D264-4FCA-8936-F26B50B7275FQ33958966-C04C01AC-850A-4E60-AA65-D293EDC00A94Q34374054-354DC101-E049-4556-AFCC-21B008FC3114Q36373813-4731BAD1-0138-4162-895D-D40F022B9A5FQ37791426-AB59E152-6F59-4AED-91D7-0285295C71FEQ38267711-62D93888-57EA-4805-B0E8-EA01BBE529B8Q39169678-F1A01CF9-71BF-4BE3-A0EA-9C94E9D07DA6Q40803963-D6FBC4CA-E1C9-42D0-BFD7-F76DED2C932FQ41877398-A84C3614-CC30-48A6-BD0E-774C02105267Q44540464-65C39A36-A377-46F2-9760-1BC8FD5EA8E0Q48018483-147AB90D-A01A-467C-8F70-1FD35CB9045DQ52653763-1F939DD0-1563-4705-9869-923E2B181809Q53192634-1C8A6A77-D9A1-422B-A10C-1C147FC80E4E
P2860
Clinical toxicity of cytokines used as haemopoietic growth factors.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Clinical toxicity of cytokines used as haemopoietic growth factors.
@ast
Clinical toxicity of cytokines used as haemopoietic growth factors.
@en
type
label
Clinical toxicity of cytokines used as haemopoietic growth factors.
@ast
Clinical toxicity of cytokines used as haemopoietic growth factors.
@en
prefLabel
Clinical toxicity of cytokines used as haemopoietic growth factors.
@ast
Clinical toxicity of cytokines used as haemopoietic growth factors.
@en
P1433
P1476
Clinical toxicity of cytokines used as haemopoietic growth factors.
@en
P2093
J Descotes
P304
P356
10.2165/00002018-199513060-00006
P50
P577
1995-12-01T00:00:00Z
P6179
1041306889